1,333
Views
6
CrossRef citations to date
0
Altmetric
Diabetes

Therapeutic inertia or individualization? Delay in clinical management of type 2 diabetes mellitus

, &
Pages 1477-1478 | Received 30 Mar 2016, Accepted 10 May 2016, Published online: 13 Jun 2016
 

Transparency

Declaration of funding

This editorial was written independently and received no professional help.

Acknowledgement

We thank Ms Michiko Yamane in Kansai Electric Power Hospital for her secretarial assistance.

Declaration of financial/other relationships

N.T. has disclosed that he has no significant relationships with or financial interests in any commercial companies related to this study or article. T.K. has disclosed that he has received consulting and/or speaker fees from Astellas, Boehringer Ingelheim, Sanofi, Novo Nordisk, MSD, Takeda, Kowa, Tanabe Mitsubishi, Kaken Pharm, AstraZeneca, Daiichi-Sankyo, and Kyowa Kirin; he has also received clinical commissioned/joint research grants from Boehringer Ingelheim, Novo Nordisk, Merck, Sharp and Dohme, Takeda, Ono Pharm, Eli Lilly, Teijin, and Sanofi. Y.S. has disclosed that he has received consulting and/or speaker fees from Eli Lilly, Sanofi, Novo Nordisk, GlaxoSmithKline, Taisho Pharmaceutical, Astellas Pharma, BD, Boehringer Ingelheim, Johnson & Johnson and Takeda.

The CMRO peer reviewer on this manuscript has no relevant financial or other relationships to disclose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.